Reverse transcriptase mutations in HIV-1 infected patients treated with two nucleoside analogues: the SMART study. (Q53940587)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Reverse transcriptase mutations in HIV-1 infected patients treated with two nucleoside analogues: the SMART study.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Reverse transcriptase mutations in HIV-1 infected patients treated with two nucleoside analogues: the SMART study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Adriano Lazzarin

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

N. Gianotti

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

M. Setti

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

P. E. Manconi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

F. Leoncini

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

F. Chiodo

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

L. Minoli

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

M. Moroni

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

G. Angarano

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

F. Mazzotta

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

G. Carosi

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

G. Antonelli

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 May 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

International Journal of Immunopathology and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

129-139

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

21 January 2018

Prevalence and clinical significance of zidovudine resistance mutations in human immunodeficiency virus isolated from patients after long-term zidovudine treatment. AIDS Clinical Trials Group 116B/117 Study Team and the Virology Committee Resistance

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

21 January 2018

A Mutation in Human Immunodeficiency Virus Reverse Transcriptase and Decline in CD4 Lymphocyte Numbers in Long-Term Zidovudine Recipients

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

21 January 2018

Dual resistance to zidovudine and lamivudine in patients treated with zidovudine-lamivudine combination therapy: association with therapy failure

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

21 January 2018

Multiple sites in HIV-1 reverse transcriptase associated with virological response to combination therapy.

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

21 January 2018

Genotypic and phenotypic analysis of human immunodeficiency virus type 1 isolates from patients on prolonged stavudine therapy

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

21 January 2018

Phenotypic and genotypic resistance patterns of HIV-1 isolates derived from individuals treated with didanosine and stavudine.

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

21 January 2018

Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC).

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

21 January 2018

Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

21 January 2018

Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team).

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

21 January 2018

Viral resistance patterns selected by antiretroviral drugs and their potential to guide treatment choice

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

21 January 2018

Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

21 January 2018

Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

21 January 2018

Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agents

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

21 January 2018

Novel mutation (V75T) in human immunodeficiency virus type 1 reverse transcriptase confers resistance to 2',3'-didehydro-2',3'-dideoxythymidine in cell culture

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

21 January 2018

Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides.

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

21 January 2018

Long-term exposure to zidovudine affects in vitro and in vivo the efficiency of phosphorylation of thymidine kinase

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

21 January 2018

Use of viral resistance patterns to antiretroviral drugs in optimising selection of drug combinations and sequences

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

21 January 2018

Mechanism of inhibition of the human immunodeficiency virus type 1 reverse transcriptase by d4TTP: an equivalent incorporation efficiency relative to the natural substrate dTTP

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

21 January 2018

Host-parasite dynamics and outgrowth of virus containing a single K70R amino acid change in reverse transcriptase are responsible for the loss of human immunodeficiency virus type 1 RNA load suppression by zidovudine

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

21 January 2018

Mechanistic studies examining the efficiency and fidelity of DNA synthesis by the 3TC-resistant mutant (184V) of HIV-1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

21 January 2018

Specific recognition of lamivudine-resistant HIV-1 by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

21 January 2018

Immunogenicity of mutations induced by nucleoside reverse transcriptase inhibitors for human immunodeficiency virus type 1-specific cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

21 January 2018

The ALBI trial: a randomized controlled trial comparing stavudine plus didanosine with zidovudine plus lamivudine and a regimen alternating both combinations in previously untreated patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

21 January 2018

Effects of discontinuation of zidovudine treatment on zidovudine sensitivity of human immunodeficiency virus type 1 isolates

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

21 January 2018

Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

21 January 2018

Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

21 January 2018

A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS.

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

21 January 2018

Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F039463200201500208

21 January 2018

Identifiers

10.1177/039463200201500208

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590875%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53940587&oldid=1042159927"